Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-05

Clinical Trial Update: Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating whether adding diacerein (100 mg daily) to methotrexate improves safety and efficacy in early rheumatoid arthritis, compared with met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diacerein (Diacerein)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: TRB Chemedica | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED